Erythropoiesis: an overview - Erythropoietins and Erythropoiesis - page 13

conformation change. Science 283: 990-993
36 Rane SG, Reddy EP (2002) JAKs, STATs and Src kinases in hematopoiesis. Oncogene 21:
3334-3358
37 Starr R, Hilton DJ (1999) Negative regulation of the JAK/STAT pathway. Bioessays 21: 47-52
38 Cantor AB, Orkin SH (2002) Transcriptional regulation of erythropoiesis: An affair involving mul-
tiple partners. Oncogene 21: 3368-3376
39 Gregory I, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ (1999) GATA-1 and erythropoietin coop-
erate to promote erythroid cell survival by regulating bcl-xL. Blood 94: 87-96
40 Gregg XT, Prchal JT (1997) Erythropoietin receptor mutations and human disease. Semin Hematol
31: 70-76
41 Watowich SS, Xie X, Klingmuller U, Kere J, Lindlof M, Berglund S, de la Chapelle A (1999)
Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to
erythropoietin in the heterozygous state. Blood 94: 2530-2532
42Silva M, Richard C, Benito A, Sanz C, Olalla I, Fernandez-Luna JL (1998) Expression of Bcl-x
in erythroid precursors from patients with polycythemia vera. N Engl J Med 338: 564-571
43 Skibeli V, Nissen-Lie G, Torjesen P (2001) Sugar profiling proves that human serum erythropoi-
etin differs from recombinant human erythropoietin. Blood 98: 3626-3634
44 Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT (1997) Angiotensin II stimulates proliferation
of normal early erythroid progenitors. J Clin Invest 100: 2310-2314
45 Gupta M, Miller BA, Ahsan N, Ulsh PJ, Zhang MY, Cheung JY, Yang HC (2000) Expression of
angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocy-
tosis. Transplantation 70: 1188-1194
46 Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk C, Delafontaine P, Bernstein KE (1995)
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375: 247-250
47Plata R, Cornejo A, Arratia C, Anabaya A, Perna A, Dimitrov BD, Remuzzi G, Rugenenti P (2002)
Angiotensin-converting-enzyme inhibition therapy in altitude polycythemia: a prospective ran-
domised trial. Lancet 359: 663-666
48 Mirza AM, Correa PN, Axelrad AA (1995) Increased basal and induced tyrosine phosphorylation
of the insulin-like growth factor I receptor β sub-unit in circulating mononuclear cells of patients
with polycythemia vera. Blood 86: 877-882
49 Mirza AM, Ezzat S, Axelrad AA (1997) Insulin-like growth factor binding protein-1 is elevated in
patients with polycythemia vera and stimulates erythroid burst formation in vitro . Blood 89:
1862-1869
50 Orkin SH, Weiss MJ (1999) Apoptosis. Cutting red-cell production. Nature 401: 435-436
51Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura I, Gondo H,
Niho Y (1995) Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells.
Blood 86: 883-889
52 DeMaria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F, Srinivasula SM, Alnemri
ES, Testa J, Peschle C (1999) Negative regulation of erythropoiesis by caspase-mediated cleavage
of GATA-1. Nature 401: 489-493
53 De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, Riccioni R, Felli N, Samoggia P
et al. (1999) Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 93:
796-803